Omega-3

Market research indicates that today’s consumers are spending more on immune-health supplements than ever. Ahead, a look at some of the latest studies on immune-health ingredients.

According to the report, the global omega-3 sector grew 1.8% between 2016 and 2017, to become a $1.29 billion industry, experiencing its third straight year of growth.

OmegaQuant Analytics, the producer of The Omega-3 Index, has launched a new Prenatal DHA Test developed for expecting mothers to monitor their omega-3 DHA level. 

The omega-3 industry will continue its efforts to overcome unfairly negative messaging about omega-3 ingredients and to highlight positive findings.

The company now operates two krill trawlers in Antarctica.

The researchers found that a high serum dihomo-γ-linolenic acid (DGLA), an omega-6 polyunsaturated fatty acid, was associated with obesity, body fat accumulation, a high alanine amino transferase level, and insulin resistance in Japanese subjects with type 2 diabetes.

Researchers have discovered two novel anti-inflammatory compounds that are converted from eicosatetraenoic acid (ETA), a long-chain omega-3 fatty acid elevated by the consumption of Ahiflower oil.

New research finds that krill oil may significantly reduce fasting blood glucose. 

The European Medicines Agency (EMA) will no longer authorize omega-3 fatty acids for secondary prevention of myocardial infarction, based on an eight-month review of research.

The Global Organization for EPA and DHA Omega-3 (GOED; Salt Lake City, UT) has issued two industry advisories addressing technical concerns related to omega-3 fatty acids EPA and DHA: one regarding micro- and nanoplastic particle contamination, and a second addressing the correct expression of EPA, DHA, and total omega-3 fatty acid content in oils.

New study contradicts theory that omega-3 fish oil can increase risk of bleeding in surgical patients.

Aker BioMarine provides updates on its research efforts in the areas of sports nutrition and lupus. 

Although researchers did not find a reduction in the primary endpoint of significantly reducing major CVD events, the study did reveal some positive, statistically significant benefits, the association says.

Amarin Pharma Inc., maker of high-concentration EPA-only omega-3 drug Vascepa, has filed false advertising lawsuits against two omega-3 dietary supplement manufacturers: Coromega Health Inc. and Omax Health Inc. 

The Global Organization for EPA and DHA Omega-3s has released a new industry advisory for how to properly express the content of omega-3 fatty acids EPA, DHA, and other fatty acids in oils. 

Not only do 75% of Americans take supplements, but 87% of U.S. adults have overall confidence in the safety, quality, and effectiveness of dietary supplement products, the survey found.

It is well known that EPA and DHA support cardiovascular and metabolic health through several mechanisms.

The Global Organization for EPA and DHA Omega-3s is making a push to spread awareness of omega-3s among healthcare professionals, including nurse practitioners, physician’s assistants, and pharmacists, with the launch of its new Fats for Life website.

The review found that the combination of omega-3s and statins for heart health can sometimes be complementary, but can also be antagonistic. The authors note that further intervention studies are needed to explore the interaction.

A new clinical trial is underway to examine the effects of krill oil on those suffering from lupus.

Amarin Corp., maker of Vascepa, a high-concentration EPA-only omega-3 drug for heart health, published the topline results from its large-scale Reduction of Cardiovascular Events with EPA Intervention Trial (REDUCE-IT).

Post-surgical immune function as well as recovery outcomes improved for GI cancer patients after short-term omega-3 supplementation, according to meta-analysis. 

An Australian company called Nuseed, a subsidiary of Nufarm Ltd., announced that USDA has deregulated the company’s proprietary omega-3 canola for cultivation in the U.S.

Higher omega-3 levels may be linked to reduced cognitive depression symptoms in heart failure patients, according to a study recently published in the Journal of the American College of Cardiology’s Heart Failure.

Bill Harris, PhD, omega-3 researcher and founder of OmegaQuant, says a recent Cochrane report is biased because it ignores a large body of evidence showing favorable effects of EPA and DHA on cardiovascular risk.